These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34509585)

  • 1. Polyplex nanomicelle delivery of self-amplifying RNA vaccine.
    Chang YH; Lin MW; Chien MC; Ke GM; Wu IE; Lin RL; Lin CY; Hu YC
    J Control Release; 2021 Oct; 338():694-704. PubMed ID: 34509585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
    Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
    Renson P; Fablet C; Andraud M; Normand V; Lebret A; Paboeuf F; Rose N; Bourry O
    Vaccine; 2019 Jul; 37(31):4318-4324. PubMed ID: 31248683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows.
    Young JE; Dvorak CMT; Graham SP; Murtaugh MP
    Front Immunol; 2021; 12():638493. PubMed ID: 33692807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.
    Lee JA; Kwon B; Osorio FA; Pattnaik AK; Lee NH; Lee SW; Park SY; Song CS; Choi IS; Lee JB
    Vaccine; 2014 Jun; 32(29):3617-22. PubMed ID: 24814552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Cross-Protective Efficacy of a Chimeric Porcine Reproductive and Respiratory Syndrome Virus Constructed Based on Two Field Strains.
    Shabir N; Khatun A; Nazki S; Kim B; Choi EJ; Sun D; Yoon KJ; Kim WI
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27556483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
    Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies of deglycosylated chimeric porcine reproductive and respiratory syndrome virus as a vaccine candidate and its realistic revenue impact at commercial pig production level.
    Kim JJ; Lee JA; Choi HY; Han JH; Huh W; Pi JH; Lee JK; Park S; Cho KH; Lee JB
    Vaccine; 2017 Sep; 35(37):4966-4973. PubMed ID: 28802752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing neutralizing antibody production by an interferon-inducing porcine reproductive and respiratory syndrome virus strain.
    Wang R; Xiao Y; Opriessnig T; Ding Y; Yu Y; Nan Y; Ma Z; Halbur PG; Zhang YJ
    Vaccine; 2013 Nov; 31(47):5537-43. PubMed ID: 24063978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
    Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
    Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
    Jeong J; Choi K; Kang I; Park C; Chae C
    Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of host immune responses to homologous and heterologous type II porcine reproductive and respiratory syndrome virus (PRRSV) challenge in vaccinated and unvaccinated pigs.
    Li X; Galliher-Beckley A; Pappan L; Trible B; Kerrigan M; Beck A; Hesse R; Blecha F; Nietfeld JC; Rowland RR; Shi J
    Biomed Res Int; 2014; 2014():416727. PubMed ID: 24719862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies.
    Vanhee M; Delputte PL; Delrue I; Geldhof MF; Nauwynck HJ
    Vet Res; 2009; 40(6):63. PubMed ID: 19674539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.